Study for the diagnosis, prognosis and mechanism of exosomes in coronary heart disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026192

Enrollment

Unknown

Registered

2019-09-26

Start date

2019-09-24

Completion date

Unknown

Last updated

2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary disease

Interventions

Patients with unstable angina pectoris treated with PCI:N/A

Patients with myocardial infarction treated with PCI:N/A

PCI excludes coronary heart disease and other cardiovascular diseases:N/A

Healthy people:N/A

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Community healthy people without any disease, no coronary heart disease and other cardiovascular diseases in hospital, inpatients tried to do coronary angiography because of unstable angina pectoris or myocardial infarction.

Exclusion criteria

Exclusion criteria: 1. Patients with infection, inflammation, autoimmune diseases, progressive liver and kidney dysfunction, tumors, trauma and surgical history in recent months. 2. Patients who refused to participate in the trial and signed informed consent. 3. Patients admitted to hospital are in critical condition and are in urgent need of rescue. 4. Patients who have nothing to do with the purpose of this study.

Design outcomes

Primary

Measure	Time frame
Exosome miR;	—

Secondary

Measure	Time frame
caspase-1, NLRP3, ASC;MMP9, PTEN;	—

Countries

China

Contacts

Public ContactChunli Song

Jilin University Second Hospital

2632494613@qq.com+86 13596052383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026